| Kasi Cassandra Saucier, | |
|
401 Baptist Dr Ste 206, Madison, MS 39110-2011 | |
| (601) 973-1583 | |
| (601) 973-1609 |
| Full Name | Kasi Cassandra Saucier |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 7 Years |
| Location | 401 Baptist Dr Ste 206, Madison, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326561721 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | A4341 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Foundation Of Central Mississippi Inc | 1153216411 | 233 |
News Archive
Babies whose mothers received steroid injections before giving birth have no higher risk of heart disease at age 30 than those whose mothers received a placebo treatment.
Laws in certain New York counties that place restrictions on adding trans fats to foods have immediately had a positive impact on the public's heart health, according to research published in JAMA Cardiology.
NovaRx Corporation announced that the detailed results from the randomized Phase III trial of Lucanix (belagenpumatucel-L) post-frontline maintenance therapy in non-small cell lung cancer will be presented at the European Society for Medical Oncology 2013 annual meeting in Amsterdam.
Med-Vision, a Tampa-based medical consulting company providing strategies to lower healthcare costs and improve quality of care, is providing free healthcare planning advice and solutions via the Web. A newly launched Insights on Healthcare Blog (http://medvision.wordpress.com/) created by Dan Ross, president of Med-Vision, offers timely healthcare commentary, insights to help healthcare consumers, and information to help self-funded employers understand complicated issues of employee benefits.
EpiCept Corporation has announced that it will study EpiCept NP-1, its patented topical cream formulation of two FDA-approved drugs, 4% amitriptyline and 2% ketamine, for the treatment of chemotherapy induced peripheral neuropathy (CPN) in the ATTRACT-CPN Phase III Study (Assessment of Topical Treatment Response with Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy).
› Verified 7 days ago
| Provider Name | Medical Foundation Of Central Mississippi Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1992774814 PECOS PAC ID: 1153216411 Enrollment ID: O20040217000380 |
News Archive
Babies whose mothers received steroid injections before giving birth have no higher risk of heart disease at age 30 than those whose mothers received a placebo treatment.
Laws in certain New York counties that place restrictions on adding trans fats to foods have immediately had a positive impact on the public's heart health, according to research published in JAMA Cardiology.
NovaRx Corporation announced that the detailed results from the randomized Phase III trial of Lucanix (belagenpumatucel-L) post-frontline maintenance therapy in non-small cell lung cancer will be presented at the European Society for Medical Oncology 2013 annual meeting in Amsterdam.
Med-Vision, a Tampa-based medical consulting company providing strategies to lower healthcare costs and improve quality of care, is providing free healthcare planning advice and solutions via the Web. A newly launched Insights on Healthcare Blog (http://medvision.wordpress.com/) created by Dan Ross, president of Med-Vision, offers timely healthcare commentary, insights to help healthcare consumers, and information to help self-funded employers understand complicated issues of employee benefits.
EpiCept Corporation has announced that it will study EpiCept NP-1, its patented topical cream formulation of two FDA-approved drugs, 4% amitriptyline and 2% ketamine, for the treatment of chemotherapy induced peripheral neuropathy (CPN) in the ATTRACT-CPN Phase III Study (Assessment of Topical Treatment Response with Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kasi Cassandra Saucier, 965 Ridge Lake Blvd Ste 103, Memphis, TN 38120-9446 Ph: () - | Kasi Cassandra Saucier, 401 Baptist Dr Ste 206, Madison, MS 39110-2011 Ph: (601) 973-1583 |
News Archive
Babies whose mothers received steroid injections before giving birth have no higher risk of heart disease at age 30 than those whose mothers received a placebo treatment.
Laws in certain New York counties that place restrictions on adding trans fats to foods have immediately had a positive impact on the public's heart health, according to research published in JAMA Cardiology.
NovaRx Corporation announced that the detailed results from the randomized Phase III trial of Lucanix (belagenpumatucel-L) post-frontline maintenance therapy in non-small cell lung cancer will be presented at the European Society for Medical Oncology 2013 annual meeting in Amsterdam.
Med-Vision, a Tampa-based medical consulting company providing strategies to lower healthcare costs and improve quality of care, is providing free healthcare planning advice and solutions via the Web. A newly launched Insights on Healthcare Blog (http://medvision.wordpress.com/) created by Dan Ross, president of Med-Vision, offers timely healthcare commentary, insights to help healthcare consumers, and information to help self-funded employers understand complicated issues of employee benefits.
EpiCept Corporation has announced that it will study EpiCept NP-1, its patented topical cream formulation of two FDA-approved drugs, 4% amitriptyline and 2% ketamine, for the treatment of chemotherapy induced peripheral neuropathy (CPN) in the ATTRACT-CPN Phase III Study (Assessment of Topical Treatment Response with Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy).
› Verified 7 days ago
Mrs. Mckenzie Russell Burns, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 414 Bozeman Rd, Madison, MS 39110 Phone: 601-914-9200 | |
Dr. Margaux Antoine Nelms, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 138 Park Place Blvd, Madison, MS 39110 Phone: 601-982-0611 | |
Tiffany B Langham, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 401 Baptist Dr Ste 204, Madison, MS 39110 Phone: 601-973-1583 Fax: 601-973-1609 | |
Carrie Tilley Snyder, AU.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 204 Key Dr Ste A, Madison, MS 39110 Phone: 601-351-5433 Fax: 601-779-9155 | |
Katie Berry, AUD., CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 401 Baptist Dr Ste 206, Madison, MS 39110 Phone: 601-973-1583 Fax: 601-973-1681 | |
Mrs. Mary Rebecca Foster, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 132 Bridge Water Drive, Madison, MS 39110 Phone: 601-898-0182 |